Abstract
BackgroundTEM β-lactamases are the main cause for resistance against β-lactam antibiotics. Sequence information about TEM β-lactamases is mainly found in the NCBI peptide database and TEM mutation table at . While the TEM mutation table is manually curated by experts in the lactamase field, who guarantee reliable and consistent information, the rapidly growing sequence and annotation information from the NCBI peptide database is sometimes inconsistent. Therefore, the Lactamase Engineering Database has been developed to collect the TEM β-lactamase sequences from the NCBI peptide database and the TEM mutation table, systematically compare sequence information and naming, identify inconsistencies, and thus provide a versatile tool for reconciliation of data and for an investigation of the sequence-function relationship.DescriptionThe LacED currently provides 2399 sequence entries and 37 structure entries. Sequence information on 150 different TEM β-lactamases was derived from the TEM mutation table which provides a unique number to each protein classified as TEM β-lactamase. 293 TEM-like proteins were found in the NCBI protein database, but only 113 TEM β-lactamase were common to both data sets. The 180 TEM β-lactamases from the NCBI protein database which have not yet been assigned to a TEM number fall in three classes: (1) 89 proteins from microbial organisms and 35 proteins from cloning or expression vectors had a new mutation profile; (2) 55 proteins had inconsistent annotation in terms of TEM assignment or reported mutation profile; (3) 39 proteins are fragments. The LacED is web accessible at and contains multisequence alignments, structure information and reconciled annotation of TEM β-lactamases. The LacED is weekly updated and supplies all data for download.ConclusionThe Lactamase Engineering Database enables a systematic analysis of TEM β-lactamase sequence and annotation data from different data sources, and thus provides a valuable tool to identify inconsistencies in sequences from the NCBI peptide database, to detect TEM β-lactamases with a novel mutation profile, and to identify new amino acid positions at which mutations can occur.
Highlights
TEM β-lactamases are the main cause for resistance against β-lactam antibiotics
The 180 TEM β-lactamases from the NCBI protein database which have not yet been assigned to a TEM number fall in three classes: (1) 89 proteins from microbial organisms and 35 proteins from cloning or expression vectors had a new mutation profile; (2) 55 proteins had inconsistent annotation in terms of TEM assignment or reported mutation profile; (3) 39 proteins are fragments
The Lactamase Engineering Database enables a systematic analysis of TEM βlactamase sequence and annotation data from different data sources, and provides a valuable tool to identify inconsistencies in sequences from the NCBI peptide database, to detect TEM βlactamases with a novel mutation profile, and to identify new amino acid positions at which mutations can occur
Summary
The amount of sequence and structure data of TEM βlactamases available in public databases is increasing rapidly. The Lactamase Engineering Database enables a systematic analysis of sequence and annotation information from different data sources. The Lactamase Engineering Database will be extended to the other lactamase families and classes. The LacED is accessible at http://www.LacED.uni-stutt gart.de by a JavaScript-enabled WWW browser. GI: GenInfo Identifier; LacED: Lactamase Engineering Database. QKT developed the database, built the web pages, analyzed the data and drafted the manuscript. FB contributed to data analysis and to writing of the manuscript. JP supervised the study and finalized the manuscript. All authors read and approved the final manuscript. This file contains tables S1, S2, S3, S4, S5, S6 mentioned in the text.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.